Dr. Dominic Clarke of HemaCare, a Charles River company, will be presenting Considerations for Global Cell Supply Chain Consistency during the Supply Security in Cell & Gene Therapy Manufacturing session. Be sure to attend the sessions and contact us to discuss your cell therapy needs.
HemaCare, a Charles River company, is pleased to participate in the program of ISPE 2020 Annual Meeting & Expo Virtual Conference. This meeting will focus on steering the future of pharmaceutical science and manufacturing toward a more global, synchronized, and quality-driven industry. The event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.
Dr. Dominic Clarke, Global Head of Cell Therapy at HemaCare and ISCT Process & Product Committee Co-Chair, will present during the following session:
Friday, November 6, 2020 | 11:35 AM – 11:50 AM EST
SESSION: SUPPLY SECURITY IN CELL & GENE THERAPY MANUFACTURING
Title: Considerations for Global Cell Supply Chain Consistency
For more information, or to request a virtual meeting, please contact firstname.lastname@example.org.